Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients

Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients

Abstract Background Non-thermal plasma (NTP) refers to an ionized gas composed of ions, electrons and other reactive agents. The anticancer properties of NTP have been proven in vitro and in vivo. The 10-year local recurrence risk (LRR) in breast cancer patients after breast conservation therapy (i....

Full description

Saved in:
Bibliographic Details
Main Authors: Audrey Glory, Erica Patocskai, Philip Wong
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Cancer
Subjects:
Non-thermal plasma
Breast cancer
Intraoperative treatment
Local recurrence risk
Online Access:https://doi.org/10.1186/s12885-025-14153-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14153-5

Similar Items